Agios Set to Sell Oncology Business for Nearly $2 Billion
shot by IP News Shots / 6:10 pm on 22 December, 2020
Agios Pharmaceuticals Inc. is all set to sell its oncology business to Servier Laboratories in a nearly $2 Billion worth deal. Agios will get up front payments along with milestone-based payment for their brain cancer drug Vorasidenib along with royalty payment for future sale of leukaemia drug, Tibsovo.
Read More at: https://www.investors.com/news/technology/agio-stock-rockets-oncology-sales-servier/